Hubei Jumpcan Pharmaceut (600566.SS) traded flat 0 % during a 24 hours period ending at 03:17 PM Central Europe on Monday 26th. One Hubei Jumpcan Pharmaceut stock can currently be bought for about CNY 26.62 on popular exchanges. Current supply of Hubei Jumpcan Pharmaceut stocks is 921.9 mn. Hubei Jumpcan Pharmaceut has a current market capitalization of CNY 24.3 bn and approximately CNY 179.7 mn worth of Hubei Jumpcan Pharmaceut was traded on exchanges in the last 24 hours. Since last month end, Hubei Jumpcan Pharmaceut has traded 8.03 % up. Simple moving average of last 200 days is at CNY 25.78. The highest price of past 52 weeks was recorded at CNY 29.6 on 05/11/2026. 52 weeks low was at CNY 21.13 on 07/01/2026.
Here is how related stocks have performed in the past 24 hours:
Guangxi Huaxi Nonferrous M (600301.SS) traded flat 0 % and now trades at CNY 45.54. Guangxi Huaxi Nonferrous M has a market capitalisation of CNY 29 bn. Current price/earnings ratio for Guangxi Huaxi Nonferrous M is 30.09.
Ubtech Robotics -H (9880.HK) traded up 6.73 % and now trades at HKD 68.5. Current market capitalisation for Ubtech Robotics -H is HKD 34.3 bn.
Shandong Xinchao Energy (600777.SS) traded flat 0 % and now trades at CNY 4.31. Current market capitalisation for Shandong Xinchao Energy is CNY 29 bn. Shandong Xinchao Energy has a current price to earnings ratio of 49.13.
Jiangsu Nata Opto-electron (300346.SZ) traded flat 0 % and now trades at CNY 40.44. Jiangsu Nata Opto-electron has a market capitalisation of CNY 29 bn. Jiangsu Nata Opto-electron has a current price to earnings ratio of 79.36.
Changchun High-tech Indust (000661.SZ) traded flat 0 % and now trades at CNY 73.44. Changchun High-tech Indust has a market capitalisation of CNY 29 bn. China’s Changchun High‑Tech Industrial Group reported a notable improvement in its business performance this year. The company’s management highlighted strengthened production capacity and an expanding order book across its main product lines. Sales and profitability rose in the most recent reporting period, reflecting increased demand for the firm’s specialty chemicals and related materials. Management also underlined ongoing investments in research and development, particularly in advanced chemical processes, as part of a broader strategy to enhance product quality and market competitiveness. While the company maintained a conservative outlook on market conditions, it emphasized its focus on sustaining growth momentum and optimizing operational efficiency. Overall, the update suggests that Changchun High‑Tech Industrial Group is progressing positively, supported by robust operational execution and strategic investment in innovation.
About Hubei Jumpcan Pharmaceut
Hubei Jumpcan Pharmaceutical Co.,Ltd. is a health care company operating in the pharmaceutical industry of China. The company produces a diverse range of pharmaceutical products including detoxification drugs, digestive drugs, nervous system drugs, anti infectives, analgesic anesthetics, hemostatic agents, gynecological drugs, and other products. Additionally, Hubei Jumpcan Pharmaceutical also produces metal materials, chemicals, and other products. The company’s website is accessible under www.jumpcan.com and it is listed on the Shanghai Stock Exchange. The Initial Public Offering (IPO) for this company took place on August 1st, 2001.
